Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zotefoams plc (ZTF.L)
GBp420.00
-11.00 (-2.55%)
GB LSE Basic Materials Chemicals - Specialty
Address
675 Mitcham Road CR9 3AL
Croydon, GB
Croydon, GB
CEO
Ronan Michael Cox
Website
zotefoams.com
IPO
1995-02-28
ISIN GB0009896605
Description
Zotefoams plc, established in 1921 and headquartered in Croydon, UK, is a global leader in the manufacturing, distribution, and sale of polyolefin block foams. The company serves markets across the United Kingdom, Continental Europe, North America, and other international regions, structured around its Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. Its product portfolio encompasses the AZOTE range of polyolefin foams, known by brands such as Plastazote, Evazote, and Supazote. Furthermore, Zotefoams develops high-performance foams under the ZOTEK brand, which are formulated from advanced materials including fluoropolymers, engineering polymers, and specialized elastomers. The company also supplies T-FIT, a sophisticated clean insulation solution vital for pharmaceutical, biotech, and semiconductor cleanroom applications. Beyond its product lines, Zotefoams possesses and licenses the patented MuCell microcellular foam technology, complementing this with the sale of related machinery. These diverse offerings are utilized across a broad spectrum of industries, notably automotive, aerospace, product protection, industrial parts, marine, building and construction, military, and sports and leisure.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
GBp420.00
-11.00 (-2.55%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
142.7K
Beta
1.24
Float Shares
43.11M
Free Float %
87.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.00% | -0.55% | +4.92% | -4.04% | -2.92% | +3.10% | +38.50% | +18.71% | -13.44% | +38.50% | +144.41% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
420.00
DCF (Levered)
596.43
+42.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 5 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
3.49
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%+7.2% ★ Q4'25: +30.0% (vs Q4'23)
-
EPS growth Chemicals - Specialty: +13.2%+895.1% ★ Q4'25: +243.9% (vs Q4'23)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+18.8% Q4'25: +20.3% (vs Q4'23)
-
EBIT margin Chemicals - Specialty: +8.8%+14.2% ★ Q4'25: +12.8% (vs Q4'23)
-
ROIC Chemicals - Specialty: +5.6%+13.0% ★ Q4'25: +23.9% (vs Q4'23)
-
Share dilution Chemicals - Specialty: +0.1%+3.7% Q4'25: +1.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.82× Q4'25: 0.97× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 1998 actual |
Dec 1999 actual |
Dec 2000 actual |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 5 Rev. Ana. 3 EPS Ana. |
Dec 2028 4 Rev. Ana. 2 EPS Ana. |
Dec 2029 3 Rev. Ana. 1 EPS Ana. |
Dec 2030 3 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
24.20M
est: 24.61M (-1.7%)
|
22.43M
est: 21.34M (+5.1%)
|
20.83M
est: 21.11M (-1.3%)
|
22.98M
est: 22.50M (+2.1%)
|
23.47M
est: 24.36M (-3.7%)
|
23.50M
est: 24.16M (-2.7%)
|
30.05M
est: 31.60M (-4.9%)
|
31.61M
est: 32.68M (-3.3%)
|
34.78M
est: 34.51M (+0.8%)
|
31.82M
est: 32.48M (-2.0%)
|
39.88M
est: 37.66M (+5.9%)
|
47.19M
est: 47.70M (-1.1%)
|
44.63M
est: 45.61M (-2.1%)
|
48.95M
est: 49.41M (-0.9%)
|
53.87M
est: 54.52M (-1.2%)
|
57.38M
est: 59.45M (-3.5%)
|
70.15M
est: 67.28M (+4.3%)
|
81.04M
est: 79.26M (+2.2%)
|
80.86M
est: 80.95M (-0.1%)
|
82.65M
est: 83.49M (-1.0%)
|
100.75M
est: 98.43M (+2.4%)
|
127.37M
est: 124.26M (+2.5%)
|
126.98M
est: 133.40M (-4.8%)
|
147.79M
est: 146.30M (+1.0%)
|
158.49M
est: 158.40M (+0.1%)
|
191.50M
190.00M – 193.00M
+20.9% YoY
|
204.24M
200.98M – 206.49M
+6.7% YoY
|
216.63M
216.62M – 216.63M
+6.1% YoY
|
200.00M
197.60M – 201.90M
-7.7% YoY
|
218.00M
215.38M – 220.07M
+9.0% YoY
|
| EBITDA |
9.86M
est: 9.45M (+4.3%)
|
7.86M
est: 8.48M (-7.3%)
|
5.36M
est: 7.84M (-31.6%)
|
-724.0K
est: 5.72M (-112.7%)
|
11.87M
est: 6.25M (+90.0%)
|
4.27M
est: 11.36M (-62.4%)
|
4.98M
est: 4.88M (+2.0%)
|
6.64M
est: 5.04M (+31.7%)
|
6.97M
est: 6.74M (+3.4%)
|
6.71M
est: 5.01M (+33.9%)
|
8.58M
est: 5.81M (+47.7%)
|
9.12M
est: 7.36M (+23.9%)
|
7.49M
est: 8.81M (-15.0%)
|
7.62M
est: 8.08M (-5.7%)
|
9.59M
est: 9.58M (+0.1%)
|
10.81M
est: 10.25M (+5.5%)
|
11.41M
est: 11.92M (-4.3%)
|
15.57M
est: 12.63M (+23.2%)
|
15.77M
est: 14.51M (+8.7%)
|
15.72M
est: 15.69M (+0.2%)
|
15.67M
est: 16.16M (-3.1%)
|
22.16M
est: 17.60M (+25.9%)
|
23.41M
est: 21.19M (+10.5%)
|
12.28M
est: 23.21M (-47.1%)
|
31.26M
est: 25.16M (+24.2%)
|
30.41M
30.18M – 30.65M
+20.9% YoY
|
32.44M
31.92M – 32.80M
+6.7% YoY
|
34.40M
34.40M – 34.40M
+6.1% YoY
|
31.76M
31.38M – 32.07M
-7.7% YoY
|
34.62M
34.21M – 34.95M
+9.0% YoY
|
| EBIT |
8.09M
est: 7.81M (+3.6%)
|
5.78M
est: 6.32M (-8.5%)
|
2.35M
est: 5.65M (-58.4%)
|
3.65M
est: 2.50M (+45.6%)
|
8.78M
est: -162.4K (+5,508.1%)
|
1.11M
est: 2.08M (-46.5%)
|
1.77M
est: 2.72M (-35.0%)
|
3.51M
est: 2.82M (+24.7%)
|
4.02M
est: 2.97M (+35.0%)
|
3.12M
est: 2.80M (+11.6%)
|
5.55M
est: 3.24M (+71.1%)
|
6.03M
est: 4.11M (+46.8%)
|
4.17M
est: 5.76M (-27.6%)
|
4.24M
est: 4.51M (-5.8%)
|
6.32M
est: 4.82M (+31.0%)
|
7.38M
est: 6.89M (+7.1%)
|
7.92M
est: 8.44M (-6.2%)
|
10.61M
est: 9.59M (+10.6%)
|
10.27M
est: 10.77M (-4.6%)
|
8.94M
est: 10.31M (-13.3%)
|
8.03M
est: 10.62M (-24.4%)
|
13.91M
est: 11.57M (+20.3%)
|
15.19M
est: 12.63M (+20.3%)
|
3.30M
est: 13.83M (-76.1%)
|
22.57M
est: 15.00M (+50.5%)
|
18.13M
17.99M – 18.27M
+20.9% YoY
|
19.34M
19.03M – 19.55M
+6.7% YoY
|
20.51M
20.51M – 20.51M
+6.1% YoY
|
18.94M
18.71M – 19.12M
-7.7% YoY
|
20.64M
20.39M – 20.84M
+9.0% YoY
|
| Net Income |
5.65M
est: 5.58M (+1.3%)
|
4.07M
est: 4.90M (-16.9%)
|
1.75M
est: 4.03M (-56.5%)
|
3.27M
est: 1.86M (+75.3%)
|
6.04M
est: 2.73M (+121.3%)
|
736.0K
est: 988.0K (-25.5%)
|
1.24M
est: 2.60M (-52.3%)
|
2.92M
est: 2.91M (+0.1%)
|
3.01M
est: 3.61M (-16.6%)
|
2.16M
est: 2.83M (-23.6%)
|
4.35M
est: 4.25M (+2.4%)
|
4.73M
est: 3.17M (+49.0%)
|
3.16M
est: 4.52M (-30.1%)
|
3.34M
est: 3.42M (-2.6%)
|
4.82M
est: 3.73M (+29.2%)
|
5.80M
est: 5.26M (+10.2%)
|
6.01M
est: 6.61M (-9.1%)
|
7.85M
est: 7.11M (+10.5%)
|
8.22M
est: 7.96M (+3.2%)
|
7.16M
est: 8.35M (-14.2%)
|
4.38M
est: 8.60M (-49.1%)
|
10.01M
est: 11.03M (-9.3%)
|
9.24M
est: 10.26M (-9.9%)
|
-2.76M
est: 11.54M (-123.9%)
|
22.64M
est: 16.25M (+39.3%)
|
19.05M
19.02M – 20.45M
+17.2% YoY
|
21.00M
20.71M – 23.64M
+10.2% YoY
|
24.35M
23.90M – 24.81M
+16.0% YoY
|
22.81M
22.45M – 23.09M
-6.4% YoY
|
25.63M
25.23M – 25.95M
+12.4% YoY
|
| SGA |
—
est: 3.31M (-100.0%)
|
—
est: 3.26M (-100.0%)
|
—
est: 3.84M (-100.0%)
|
—
est: 4.49M (-100.0%)
|
2.15M
est: 4.15M (-48.1%)
|
2.05M
est: 4.05M (-49.4%)
|
1.77M
est: 6.18M (-71.3%)
|
2.19M
est: 6.39M (-65.7%)
|
2.36M
est: 6.75M (-65.1%)
|
1.87M
est: 6.35M (-70.6%)
|
2.53M
est: 7.49M (-66.2%)
|
7.64M
est: 9.49M (-19.5%)
|
7.46M
est: 7.30M (+2.1%)
|
7.27M
est: 8.08M (-10.0%)
|
10.94M
est: 8.14M (+34.4%)
|
12.69M
est: 11.93M (+6.4%)
|
16.11M
est: 14.70M (+9.6%)
|
17.57M
est: 19.06M (-7.8%)
|
19.49M
est: 17.67M (+10.3%)
|
18.67M
est: 19.80M (-5.7%)
|
18.43M
est: 20.39M (-9.6%)
|
24.80M
est: 22.21M (+11.7%)
|
25.92M
est: 25.68M (+0.9%)
|
28.00M
est: 26.48M (+5.8%)
|
30.33M
est: 30.50M (-0.6%)
|
36.87M
36.58M – 37.16M
+20.9% YoY
|
39.32M
38.69M – 39.76M
+6.7% YoY
|
41.71M
41.71M – 41.71M
+6.1% YoY
|
38.51M
38.04M – 38.87M
-7.7% YoY
|
41.97M
41.47M – 42.37M
+9.0% YoY
|
| EPS |
0.16
est: 0.14 (+16.4%)
|
0.11
est: 0.11 (-3.0%)
|
0.05
est: 0.07 (-27.7%)
|
0.09
est: 0.08 (+18.2%)
|
0.17
est: 0.04 (+293.0%)
|
0.02
est: 0.02 (-2.9%)
|
0.03
est: 0.05 (-37.2%)
|
0.08
est: 0.06 (+31.6%)
|
0.08
est: 0.08 (+10.4%)
|
0.06
est: 0.06 (-1.2%)
|
0.12
est: 0.09 (+35.5%)
|
0.12
est: 0.12 (-2.6%)
|
0.08
est: 0.08 (-2.9%)
|
0.08
est: 0.11 (-25.0%)
|
0.11
est: 0.11 (-3.7%)
|
0.13
est: 0.13 (+1.0%)
|
0.14
est: 0.16 (-10.3%)
|
0.17
est: 0.18 (-6.5%)
|
0.17
est: 0.15 (+13.9%)
|
0.15
est: 0.14 (+6.3%)
|
0.09
est: 0.12 (-27.3%)
|
0.21
est: 0.19 (+9.3%)
|
0.19
est: 0.20 (-6.7%)
|
-0.06
est: 0.23 (-124.7%)
|
0.46
est: 0.32 (+43.5%)
|
0.39
0.38 – 0.41
+21.9% YoY
|
0.43
0.41 – 0.47
+9.7% YoY
|
0.48
0.47 – 0.49
+12.6% YoY
|
0.45
0.44 – 0.46
-6.4% YoY
|
0.51
0.50 – 0.51
+12.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
78.96M
OE per share TTM
1.58
Owner's Yield
38.83%
Maintenance CapEx ratio
76.07%
Maint CapEx / Avg PPE
81.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 6 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis International Small Cap Equity ETF AVDS | 0.01% | 26.0K | 0.30% |
| 2 | State Street SPDR FTSE UK All Share UCITS ETF (Dist) FTAD.L | 0.01% | 61.5K | 0.20% |
| 3 | State Street SPDR FTSE UK All Share UCITS ETF (Acc) FTAL.L | 0.01% | 61.5K | 0.20% |
| 4 | Avantis Responsible International Equity ETF AVSD | 0.00% | 16.4K | 0.23% |
| 5 | Avantis International Small Cap Value ETF AVDV | 0.00% | 611.9K | 0.36% |
| 6 | Avantis Global Small Cap Value UCITS ETF AVGS.L | 0.00% | 31.0K | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
38.3K
Shares Outstanding
49.18M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ronan Michael Cox | Group Chief Executive Officer & Executive Director | 930.9K | male |
| Nicholas James Wright | Chief Financial Officer & Executive Director | 188.9K | male |
| Dan Lumpkin | Managing Director of North America | — | male |
| Emma Marie Woollard CIMA | General Counsel & Company Secretary | — | female |
| Hugh Morgan | Managing Director of Footwear | — | male |
| Simon Jones | MD of EMEA & North America and Global Supply Chain Director | — | male |
| Simon Philip Comer | Chief Strategy & Innovation Officer | — | male |
| Brandon Thomas | Managing Director of Asia | — | male |
| Tamara Thomas | Group Sustainability & ESG Manager | — | — |
| Clare Farmer | Chief People Officer | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ZTF.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
